Bologna-Molina R, Pereira-Prado V,
Sánchez-Romero C, Tapia-Repetto G, Soria S, Hernandez M, Gónzalez-Gónzalez R,
Molina-Frechero N, Mikami
T. Expression of hMLH1 and hMSH2 proteins
in ameloblastomas and tooth
germs. Med Oral Patol Oral Cir Bucal. 2018 Mar 1;23 (2):e126-31.
doi:10.4317/medoral.22210
http://dx.doi.org/doi:10.4317/medoral.22210
|
1. Hao-bo L,
Ying-Huai Z, Hui-Zhen C, Yong C. Expression of
human DNA mismatch repair protein, hMSH2, in patients with oral lichen
planus. Exp Therapeutic Med. 2015;9:203-6. |
|
|
|
|
|
2. Fink D, Nebel
S, Aebi S, Zheng H, Kim HK, Christen RD, et al.
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal
human tissues. Br J Cancer. 1997;76:890-3. |
|
|
|
|
|
3. Leach FS, Polyak
K, Burell M, Johnson KA, Hill D, Dunlop MG, et al.
Expression of the human mismatch gene hMSH2 in normal and neoplastic tissues.
Cancer Research. 1996;56:235-40. |
|
|
|
|
|
4. Kunkel TA, Erie DA. DNA mismatch repair. Annu. Rev. Biochem. 2005;74:681-10. |
|
|
|
|
|
5. Lo Muzio L, Nocini
P, Mignogna MD, Pannone
G, Staibano S, Procaccini
M, et al. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral SCC. Anticancer Res. 1999;19:933-40. |
|
|
|
|
|
6. Fernandes
AM, De Souza VR, Springer CR, Cardoso SV, Loyola AM, Mesquita
RA, et al. Tobacco and inflammation effects in immunoexpression
of hMSH2 and hMLH1 in epithelium of oral mucosa. Anticancer Res. 2007;27:2433-37. |
|
|
|
|
|
7. Shia J, Ellis NA, Klimstra
DS. The utility of immunohistochemical detection of
DNA mismatch repair gene proteins. Virchows Arch.
2004;445:431-41. |
|
|
|
|
|
8. Wang Y, Zhou X, Song Y, Ji X, Zhang A,
Zhang G, et. al. The mismatch repair gene hPMS1 (human postmeiotic
segregation1) is down regulated in oral squamous cell carcinoma. Gene. 2013;524:28-34. |
|
|
|
|
|
9. Kolodner R.
Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev.
1996;10:1433-42. |
|
|
|
|
|
10. Edelbrock
MA, Kaliyaperumal S, Williams KJ. Structural,
molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair,
damage signaling and other noncanonical activities.
Mutat Res. 2013;743-744:53-66. |
|
|
|
|
|
11. Jessri M, Dalley AJ, Farah CS. MutSα and MutLα immunoexpression
analysis in diagnostic grading of oral epithelial dysplasia and squamous cell
carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:74-82. |
|
|
|
|
|
12. Jessri M, Dalley AJ, Farah CS. Hmsh6: a potential diagnostic marker
for oral carcinoma in situ. J Clin Pathol. 2015;68:86-90. |
|
|
|
|
|
13. Castrilli
G, Piantelli M, Artese L,
Perfetti G, Rubini C, Fioroni M, et al. Expression of Hmsh2 Hmlh1 proteins of
the human DNA mismatch repair system in ameloblastoma.
J Oral Pathol Med. 2001;30:305-8. |
|
|
|
|
|
14. Amaral-Silva
GKD, Sánchez-Romero C, Wagner VP, et al. Prognostic significance of hMSH2,
hMSH3, and hMSH6 expression in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:286-295. |
|
|
|
|
|
15. Tumuluri V,
Thomas GA, Fraser IS. Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J
Oral Pathol Med. 2002;31:598-04. |
|
|
|
|
|
16. Bologna-Molina R, Mosqueda-Taylor
A, Molina-Frechero N, Mori-Estevez AD, Sánchez-Acu-a G. Comparison of the value of PCNA and Ki-67 as
markers of cell proliferation in ameloblastic tumors.
Med Oral Patol Oral Cir Bucal.
2013;18:e174-9. |
|
|
|
|
|
17. Liu T, Wahlberg S, Burek E, Lindblom P, Rubio C, Lindblom A. Microsatellite instability as a predictor of
a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes
Chrom Cancer. 2000;27:17-25. |
|
|
|
|
|
18. El-Naggar AK, Chan JCK, Grandis JR et al, (Eds.) WHO
Classification of Head and Neck Tumours. ed 4. IARC, Lyon, France; 2017. |
|
|
|
|
|
19. Bologna-Molina R, Damián-Matsumura
P, Molina-Frechero N. An easy cell counting method
for immunohistochemistry that does not use an image analysis program. Histopathology. 2011;59:801-3 |
|
|
|
|
|
20. Hatakeyama S, Mizusawa
N, Tsutsumi R, Yoshimoto
K, Mizuki H, Yasumoto S,
et al. Establishment of human dental epithelial
cell lines expressing ameloblastin and enamelin by transfection of hTERT and cdk4 cDNAs. J Oral Pathol Med. 2011;40:227-34. |
|
|
|
|
|
21. Mach CM, Kim J, Soibam
B, Creighton CJ, Hawkins SM, Zighelboim I, et. al.
Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary
serous carcinomas. Cancer Lett. 2013;335:314-22. |
|
|
|
|
|
22. Santarpia L, Nicoloso
M, Calin GA. MicroRNAs:
a complex regulatory network drives the acquisition of malignant cell
phenotype. Endoc Relat
Cancer. 2010;17:F51-75. |
|
|
|
|
|
23. Amira AT, Mouna
T, Ahlem B, Raoudha A,
Majid BH, Amel H, et al. Immunohistochemical
expression pattern of MMR protein can specifically identify patients with
colorectal cancer microsatellite instability. Tumor Biol. 2014;35:6283-91. |
|
|
|
|
|
24. Chiaravalli
AM, Furlan D, Facco C, Tibiletti MG, Dionigi A, Casati B, et al. Immunohistochemical
pattern of Hmsh2/Hmlh1 in familial and sporadic colorectal, gastric,
endometrial and ovarian carcinomas with instability in microsatellite
sequences. Virchows Arch.
2001;438:39-48. |
|
|
|
|
|
25. Ren R, Ocampo A, Liu
GH, Izpisua Belmonte JC. Regulation
of Stem Cell Aging by Metabolism and Epigenetics. Cell Metab.
2017;26:460-474. |
|
|
|
|
|
26. Nagasaka T,
Rhees J, Kloor M, Gebert J, Naomoto Y, Boland CR,
Goel A. Somatic hypermethylation
of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. Cancer Res. 2010;70:3098-108. |
|
|
|
|
|
27. Liu K, Zuo
C, Luo QK, Suen JY, Hanna E, Fan CY. Promoter
hypermethylation and inactivation of hMLH1, a DNA
mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol.
2003;12:50-6. |
|
|
|
|
|
28. Sancar A,
Lindsey-Boltz LA, Unsal-Kaçmaz
K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage
checkpoints. Annu Rev
Biochem. 2004;73:39-85. |
|
|
|
|
|
29. Calin GA,
Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-66. |
|
|
|
|
|
30. Liu WJ, Zhao YP, Zhang TP, Zhou L,
Cui QC, Zhou WX, et al. MLH1 as a direct target of MiR-155 and a potential
predictor of favorable prognosis in pancreatic cancer. J Gastrointest
Surg. 2013;17:1399-405. |
|
|
|
|
|
31. Amaral-Silva
GK, Martins MD, Pontes HA, Fregnani ER, Lopes MA,
Fonseca FP, et al., Mismatch repair system proteins in oral benign and
malignant lesions. J Oral Pathol Med.
2017;46:241-245. |
|